Table 1.
Transplant indication prevalence (N = 94,539 respondent families)
| Indicationa | Families reporting transplant indication (%)b | Families reporting transplant indication (not in child donor) (%)b |
|---|---|---|
| Non-Hodgkin’s lymphoma | 323 (0.34) | 314 (0.33) |
| Hodgkin’s lymphoma | 290 (0.31) | 287 (0.30) |
| Acute lymphoblastic leukemia | 328 (0.35) | 263 (0.28) |
| Sarcoma | 144 (0.15) | 125 (0.13) |
| Acute myelogenous leukemia | 113 (0.12) | 106 (0.11) |
| Sickle cell disease | 121 (0.13) | 105 (0.11) |
| Beta thalassemia major | 97 (0.10) | 90 (0.10) |
| Chronic lymphocytic leukemia | 88 (0.09) | 85 (0.09) |
| Chronic myelogenous leukemia | 82 (0.09) | 82 (0.09) |
| Neuroblastoma | 90 (0.10) | 61 (0.06) |
| Multiple myeloma | 60 (0.06) | 58 (0.06) |
| Severe aplastic anemia | 49 (0.05) | 45 (0.05) |
| Myelodysplastic syndrome | 20 (0.02) | 19 (0.02) |
| Diamond–Blackfan anemia | 10 (0.01) | 9 (0.01) |
| Fanconi anemia | 8 (0.01) | 6 (0.01) |
| Hurler syndrome | 0 (0.00) | 0 (0.00) |
| Families reporting at least 1 transplant indication | 1823 (1.93) | 1655 (1.75) |
| Unique families reporting at least 1 transplant indication | 1757 (1.86)c | 1546 (1.64)c |
aFamilies may report more than one indication. Ordered by percent of families reporting indication (not in child donor)
bAdjusted using inverse probability weighting based on respondent age, age of child, and number of cord blood units
cPercent represents total unique families reporting at least one transplant indication divided by the total families responding. This total is lower than the sum of all specific transplant indications reported because families with more than 1 transplant indication were only counted once here